TrialCells2019

A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.

Gionata Fiorino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.